FDA cites compounder for making tainted version of KV's Makena

Save

After the FDA approved KV Pharmaceutical's Makena in 2011, the drugmaker asked the agency to stop compounding pharmacies from making their much cheaper versions of the drug. KV filed for bankruptcy reorganization after the agency turned its back on the request, but the FDA may now be coming around.